| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology and Metabolism Service (S.T., J.L., M.H., Y.N., N.K., E.B.-S., O.S., E.N., T.P., B.G.), Internal Medicine Department, and Department of Pediatrics (D.Z., H.L.), Hadassah-Hebrew University Medical School, Jerusalem 91120, Israel; Departments of Medicine and Cellular and Molecular Biology (A.C., L.A.-B.), Baylor College of Medicine, Houston, Texas 77030; School of Biological Science (K.E.C., M.J.D.), The University of Manchester, Manchester M13 9PT, United Kingdom; The London Centre for Childhood Pancreatic Disease (K.H., K.L.), Great Ormond Street Hospital for Children National Health Service Trust, London WC1N 3JH, United Kingdom; The Institute of Child Health (K.H., K.L.), London WC1N 3JH, United Kingdom; Pediatric Endocrine Unit (Y.T.-R.), Ha Emek Medical Center, Afula 18101, Israel; Institute for Endocrinology and Diabetes (L.D.V.), National Center for Childhood Diabetes, Schneider Childrens Medical Center of Israel, Petah Tikva 49202 and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel; Hospital Infantil Universitario Niño Jesús (J.A.), E-28009 Madrid, Spain; Hospital Infantil Universitario La Paz (R.G.), E-28034 Madrid, Spain; and Pediatric Endocrinology Clinic (A.E.), Pediatric Department, Meir General Hospital, Kfar-Saba, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel
Address all correspondence and requests for reprints to: Benjamin Glaser, M.D., Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. E-mail: beng{at}cc.huji.ac.il.
Hyperinsulinism of infancy is a genetically heterogeneous disease characterized by dysregulation of insulin secretion resulting in severe hypoglycemia. To date, mutations in five different genes, the sulfonylurea receptor (SUR1, ABCC8), the inward rectifying potassium channel (KIR6.2, KCNJ11), glucokinase (GCK), glutamate dehydrogenase (GLUD1), and short-chain 3-hydroxyacyl-coenzyme A dehydrogenase (SCHAD), have been implicated. Previous reports suggest that, in 40% of patients, no mutation can be identified in any of these genes, suggesting additional locus heterogeneity. However, previous studies did not screen all five genes using direct sequencing, the most sensitive technique available for mutation detection. We selected 15 hyperinsulinism of infancy patients and systematically sequenced the promoter and all coding exons and intron/exon boundaries of ABCC8 and KCNJ11. If no mutation was identified, the coding sequence and intron/exon boundaries of GCK, GLUD1, and SCHAD were sequenced. Seven novel mutations were found in the ABCC8 coding region, one mutation was found in the KCNJ11 coding region, and one novel mutation was found in each of the two promoter regions screened. Functional studies on ß-cells from six patients showed abnormal ATP-sensitive K+ channel function in five of the patients; the sixth had normal channel activity, and no mutations were found. Photolabeling studies using a reconstituted system showed that all missense mutations altered intracellular trafficking. Each of the promoter mutations decreased expression of a reporter gene by about 60% in a heterologous expression system. In four patients (27%), no mutations were identified. Thus, further genetic heterogeneity is suggested in this disorder. These patients represent a cohort that can be used for searching for mutations in other candidate genes.
This article has been cited by other articles:
![]() |
C James, R R Kapoor, D Ismail, and K Hussain The genetic basis of congenital hyperinsulinism J. Med. Genet., May 1, 2009; 46(5): 289 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B T Christesen, N. D Tribble, A. Molven, J. Siddiqui, T. Sandal, K. Brusgaard, S. Ellard, P. R Njolstad, J. Alm, B. Brock Jacobsen, et al. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation. Eur. J. Endocrinol., July 1, 2008; 159(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abdulhadi-Atwan, J. D. Bushman, S. Tornovsky-Babaey, A. Perry, A. Abu-Libdeh, B. Glaser, S.-L. Shyng, and D. H. Zangen Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence Diabetes, July 1, 2008; 57(7): 1935 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hussain, S. E. Flanagan, V. V. Smith, M. Ashworth, M. Day, A. Pierro, and S. Ellard An ABCC8 Gene Mutation and Mosaic Uniparental Isodisomy Resulting in Atypical Diffuse Congenital Hyperinsulinism Diabetes, January 1, 2008; 57(1): 259 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Yan, Y.-W. Lin, C. MacMullen, A. Ganguly, C. A. Stanley, and S.-L. Shyng Congenital Hyperinsulinism Associated ABCC8 Mutations That Cause Defective Trafficking of ATP-Sensitive K+ Channels: Identification and Rescue Diabetes, September 1, 2007; 56(9): 2339 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Yan, C.-W. Lin, E. A. Cartier, and S.-L. Shyng Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1351 - C1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marthinet, A. Bloc, Y. Oka, Y. Tanizawa, B. Wehrle-Haller, V. Bancila, J.-M. Dubuis, J. Philippe, and V. M. Schwitzgebel Severe Congenital Hyperinsulinism Caused by a Mutation in the Kir6.2 Subunit of the Adenosine Triphosphate-Sensitive Potassium Channel Impairing Trafficking and Function J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5401 - 5406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |